Five Women Critical After C-Section Delivery At Jodhpur’s Umaid Hospital

While two of them have been put on ventilators, three others are undergoing treatment in the ICU. Specialists from the Gynaecology department are attending them.

Jodhpur: Five women who underwent a C-section delivery at the Umaid Hospital in Rajasthan’s Jodhpur deteriorated following heavy bleeding. While two of them have been put on ventilators, three others are undergoing treatment in the ICU.

Dr BS Jodha, principal of SN Medical College, said such situations arise due to complications in various cases. “A team of doctors is monitoring all the patients. It would be premature to pinpoint a specific cause now. Every precaution is being taken, and the drug department has been contacted,” he added.

Hospital superintendent Dr Mohan Makwana said specialists from the Gynaecology department are attending to the critically ill women.

Umaid Hospital typically handles 60 to 70 deliveries a day, of which about 30 are C-sections. However, in the last two days, the number of Caesarean operations has surged to 60.

Doctors explain that pregnant women showing even minor complications at rural health centres or private hospitals are being referred to Umaid Hospital, leading to a sudden increase in the patient inflow. There has been a rise in referral cases following similar incidents reported elsewhere in the state recently.

Earlier, the health of eight women had deteriorated after C-section deliveries at Paota district hospital, and two of them had to be referred to AIIMS.

However, subsequent investigations showed normal infection reports for all medicines and equipment, and all patients have since recovered and been discharged. The recent incident from the Umaid Hospital has put the health department on high alert.

 

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care